Global Health LimitedMEDANTACorporate

Healthcare Medical Care Facilities Latest results: Jun 2026 15 quarters of data

₹1,240.00

MCap ₹33,321 Cr · P/E 60.3

Global Health Limited — Stock analysis & AI research Global Health Limited — Multibagger AI analysis Global Health Limited — Seasonality — best & worst months Global Health Limited — Technical indicators & charts Global Health Limited — Technical setup — score, trend, support & resistance Global Health Limited — Live exchange announcements

📋 Small Cap Stocks List 📈 RSI Oversold Stocks 📈 20-Day Breakdown Stocks 📈 Lowest Technical Score 🏭 Healthcare sector

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹1,304 Cr

Sales · Jun 2026

+26.5% YoY

₹287 Cr

Operating Profit · Jun 2026

+26.3% YoY

22.0%

OPM % · Jun 2026

+0.0% YoY

₹157 Cr

Net Profit · Jun 2026

-1.1% YoY

₹5.91

EPS · Jun 2026

-0.2% YoY

📝 Global Health Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Global Health Limited reported revenue of ₹1,304 crore for the quarter ended June 2026 (Q1 FY27), up 26.5% from ₹1,031 crore in the same quarter last year, and up 12.5% sequentially over the March 2026 quarter.

Net profit fell 1.1% year-on-year to ₹157 crore, from ₹159 crore. Earnings per share (EPS) came in at ₹5.91.

Operating profit stood at ₹287 crore — an operating margin (OPM) of 22.0%, compared with 22.0% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Global Health Limited posted revenue of ₹4,410 crore, a growth of 19.4% over FY25, with a net profit of ₹554 crore (up 15.1% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹4,683 crore with a net profit of ₹553 crore.

Valuation snapshot

At the current price of ₹1,240.00, MEDANTA has a market capitalisation of ₹33,321 crore and a trailing P/E of about 60.3.

Within the Medical Care Facilities industry, it is the 6th-largest of the 11 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 33.00%, foreign institutional investors (FIIs) 9.46%, domestic institutional investors (DIIs) 16.89%, public shareholders 40.56% of Global Health Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹33,321 Cr

Current Price ?

₹1,240.0

P/E ?

60.29above ind

Industry P/E ?

56.40

P/B ?

8.41

P/S ?

7.11

P/FCF ?

-126.70

Enterprise Value ?

₹34,511 Cr

EV/EBITDA ?

35.25

PEG ?

3.01

Earnings Yield ?

2.1%

Dividend Yield ?

0.04%

Profitability & Returns

Sales (TTM) ?

₹4,683 Cr

OPM ?

20.9%

Profit after tax (TTM) ?

₹553 Cr

EPS (TTM) ?

₹20.57

ROCE ?

17.0%

ROE ?

13.9%

ROA ?

9.4%

Growth

Sales — latest qtr ?

₹1,304 Cr

PAT — latest qtr ?

₹157 Cr

YoY qtr sales growth ?

26.5%

YoY qtr profit growth ?

-1.1%

Sales growth (3y) ?

18%

Sales growth (5y) ?

25%

Profit growth (3y) ?

20%

Profit growth (5y) ?

81%

Financial Health

Debt ?

₹1,190 Cr

Debt to Equity ?

0.30

Interest Coverage ?

8.8

Current Ratio ?

N/A

Ownership

Promoter holding ?

33.00%

Change in promoter holding ?

-0.01%

Pledged percentage ?

N/A

Market

Return 3 months ?

-5.8%

Return 6 months ?

13.8%

🗓️ Quarterly results (15 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	694	703	773	844	833	809	861	957	943	931	1,031	1,099	1,121	1,159	1,304	+26.5%	+12.5%
Operating Profit	160	163	178	213	212	179	186	228	238	225	227	231	217	244	287	+26.3%	+17.5%
Other Income	12	28	21	21	22	27	22	18	16	23	20	20	22	37	22	+8.3%	-40.1%
Interest	21	20	18	20	18	18	18	16	16	15	14	17	22	27	27	+93.5%	-1.2%
Depreciation	39	38	40	43	44	45	47	49	48	49	45	50	61	67	69	+52.9%	+3.0%
Profit Before Tax	112	133	141	171	172	143	144	181	189	133	208	200	120	187	213	+2.5%	+14.0%
Net Profit	81	101	102	125	124	127	106	131	143	101	159	158	95	142	157	-1.1%	+10.7%
EPS	3.08	3.77	3.80	4.66	4.61	4.74	3.96	4.87	5.32	3.77	5.92	5.89	3.54	5.36	5.91	-0.2%	+10.3%
OPM %	23.0%	23.2%	23.0%	25.2%	25.5%	22.2%	21.6%	23.8%	25.2%	24.1%	22.0%	21.0%	19.4%	21.1%	22.0%	+0.0%	+4.3%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	FY25	FY26	TTM	YoY %
Sales	₹3,693 Cr	₹4,410 Cr	₹4,683 Cr	+19.4%
Operating Profit	₹877 Cr	₹919 Cr	₹979 Cr	+4.8%
OPM %	23.74%	20.84%	20.90%	-12.2%
NPM %	13.04%	12.57%	11.80%	-3.6%
Other Income	₹79 Cr	₹99 Cr	₹101 Cr	+25.5%
Depreciation	₹193 Cr	₹223 Cr	₹247 Cr	+15.4%
Interest	₹65 Cr	₹79 Cr	₹92 Cr	+21.6%
EBIT	₹683 Cr	₹696 Cr	₹732 Cr	+1.9%
PBT	₹647 Cr	₹715 Cr	₹720 Cr	+10.4%
Tax	₹116 Cr	₹115 Cr	₹122 Cr	-0.3%
Net Profit	₹482 Cr	₹554 Cr	₹553 Cr	+15.1%
EPS	₹17.92	₹20.71	₹20.70	+15.6%
Material Cost	₹650 Cr	₹756 Cr	₹809 Cr	+16.3%
Employee Cost	₹610 Cr	₹811 Cr	₹874 Cr	+33.0%
Extraordinary Items	₹-50 Cr	₹72 Cr	₹53 Cr	+244.7%

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	54	54	54	54	+0.0%
Reserves	2,375	2,852	3,333	3,908	+17.3%
Borrowings	1,122	802	718	1,190	+65.7%
Other Liabilities	547	572	662	753	+13.7%
Total Liabilities	4,097	4,280	4,766	5,905	+23.9%
Fixed Assets	2,050	2,236	2,514	3,795	+51.0%
CWIP	327	388	533	132	-75.2%
Investments	0	0	3	3	+0.0%
Other Assets	1,720	1,656	1,716	1,975	+15.1%
Total Assets	4,097	4,280	4,766	5,905	+23.9%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	645	612	624	714	+14.4%
Cash from Investing Activity	-342	-441	-721	-1,089	-51.0%
Cash from Financing Activity	346	-514	-97	272	+380.4%
Net Cash Flow	648	-343	-194	-103	+46.9%
Free Cash Flow	409	335	110	-263	-339.1%
CFO/OP	118%	98%	89%	91%	+2.2%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	26	24	29	34	+17.2%
Inventory Days	35	32	28	29	+3.6%
Days Payable	114	90	81	89	+9.9%
Cash Conversion Cycle	-52	-34	-24	-26	-8.3%
Working Capital Days	-37	-32	-21	-7	+66.7%
ROCE %	17%	20%	20%	17%	-15.0%

👥 Shareholding (latest 5 periods)

Metric	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	% Chg
Promoters	33.01%	33.01%	33.01%	33.01%	33.00%	-0.0%
FIIs	11.54%	11.41%	10.54%	10.15%	9.46%	-6.8%
DIIs	12.20%	12.97%	13.99%	14.76%	16.89%	+14.4%
Public	43.19%	42.56%	42.41%	42.01%	40.56%	-3.5%
Others	0.06%	0.06%	0.06%	0.08%	—	—
No. of Shareholders	1,56,372	1,55,806	1,51,241	1,47,390	1,40,531	-4.7%

⚖️ Peer comparison

Industry: Medical Care Facilities · 11 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	APOLLOHOSP Apollo Hospitals	₹7,988.50	114,862	59.2	25,229	2,002	14.9%	7.9%	15.8%	33.1%	18.1%	32.9%
2	MAXHEALTH Max Healthcare	₹1,037.70	101,000	69.2	8,712	1,457	26.6%	16.7%	19.1%	34.1%	16.7%	4.9%
3	MANIPALHOS Manipal Health	₹710.85	93,504	—	—	—	—	—	—	—	28.2%	-8.3%
4	FORTIS Fortis Healthcare	₹887.80	67,025	64.3	9,128	1,064	22.8%	11.7%	17.3%	31.4%	17.8%	44.1%
5	ASTERDM Aster DM	₹763.50	66,552	198.5	4,876	363	19.0%	7.5%	44.2%	138.8%	21.6%	-68.9%
6	MEDANTA Global Health	₹1,445.60	38,846	69.8	4,683	553	20.9%	11.8%	19.4%	15.1%	26.5%	-1.1%
7	NH Narayana Hrudayalaya	₹1,869.90	37,978	46.6	9,073	817	19.3%	9.0%	41.4%	1.9%	78.0%	5.4%
8	KIMS Krishna Institute	₹767.50	30,711	148.9	4,214	194	19.8%	4.6%	28.7%	-41.5%	35.3%	-56.0%
9	RAINBOW Rainbow Children's	₹1,450.00	14,710	51.6	1,820	290	31.6%	15.9%	12.4%	15.2%	33.2%	16.2%
10	GAUDIUMIVF Gaudium IVF	₹116.42	847	36.4	106	23	32.9%	21.8%	—	—	9.1%	-42.2%
11	MOMSBELIEF Rays of Belief	₹223.00	466	—	—	—	—	—	—	—	136.4%	616.1%

❓ Frequently asked questions

What was Global Health Limited's revenue in Q1 FY27?

What was Global Health Limited's net profit in Q1 FY27?